Consensus NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Market Closed - NSE India S.E. Other stock markets 12:43:48 26/04/2024 BST			5-day change	1st Jan Change
1,028 ^INR	+0.66%		+2.85%	+26.69%

04-09	Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit	MT
03-27	NATCO Pharma Limited Announces Board Appointments	CI

Evolution of the average Target Price on NATCO Pharma Limited

Price target over the last 5 years

History of analyst recommendation changes

24ec89585b2238c7143f73e9d.mF9WuFW_aZIpoolQoVDwRjlkhsZc4h2Dy4QDs9wN2TM.3ikHygP-J6BD2_kP7RndMg0t6rEMi07hiOll2ao860fRPD-MB_Uo-h3jvQ~1863b318d7a83d663abfbe48a0e67b4b

Analyst Recommendations on NATCO Pharma Limited

Indian shares set to open higher after US data lifts sentiment

16/06/23

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1,028 INR

Average target price

975.4 INR

Spread / Average Target

-5.11%

High Price Target

1,200 INR

Spread / Highest target

+16.74%

Low Price Target

620 INR

Spread / Lowest Target

-39.68%

Consensus detail

Consensus revision (last 18 months)

Ratings for NATCO Pharma Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar